← Back to Search

Cementless Hip Replacement

Trident II Tritanium Acetabular Shell for Revision in Hip Revision Surgery

N/A

Waitlist Available

Research Sponsored by Stryker Orthopaedics

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks, 3-6 months, 1 year and 2 years

Awards & highlights

Study Summary

This trial will compare the long-term outcomes of two types of hip replacement surgeries.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks, 3-6 months, 1 year and 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks, 3-6 months, 1 year and 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks, 3-6 months, 1 year and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Cases Free From Trident II Acetabular Shell Revision

Secondary outcome measures

Radiographic Stability

Trial Design

1Treatment groups

Experimental Treatment

Group I: Trident II Tritanium Acetabular Shell for RevisionExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stryker OrthopaedicsLead Sponsor

77 Previous Clinical Trials

20,216 Total Patients Enrolled

Media Library

Trident II Tritanium Acetabular Shell (Cementless Hip Replacement) Clinical Trial Eligibility Overview. Trial Name: NCT04317586 — N/A

Hip Revision Surgery Research Study Groups: Trident II Tritanium Acetabular Shell for Revision

Hip Revision Surgery Clinical Trial 2023: Trident II Tritanium Acetabular Shell Highlights & Side Effects. Trial Name: NCT04317586 — N/A

Trident II Tritanium Acetabular Shell (Cementless Hip Replacement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04317586 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial limited to younger participants, or can individuals who are over 35 years old join?

"The primary criterion of this clinical trial is that participants must be 18 years old or above and below 85."

Answered by AI

How many research hubs are administrating this experiment?

"At this time, 10 different medical sites are recruiting patients for the study. The participating cities include Reno, New york and Salt Lake City amongst other locales. It is recommended that individuals select a clinic closest to their location in order to minimize travel requirements if they elect to take part in the trial."

Answered by AI

Are there still opportunities to contribute to this research endeavor?

"Affirmative. According to clinicaltrials.gov, this research study is actively enrolling participants and was first launched on June 23rd 2020. Ten different medical facilities are recruiting 347 patients in total for the trial."

Answered by AI

To what extent is this research involving participants?

"This clinical trial necessitates the enrolment of 347 eligible applicants. The Reno Orthopedic Center Foundation in Nevada and Syracuse Orthopedic Specialists in New york are two centres where patients can take part in this research project."

Answered by AI

To whom is this clinical investigation open?

"Patients who have undergone arthroplasty, and are between 18 to 85 years old, can be eligible for this trial. As of now, the program is accepting a maximum of 347 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Trident II Revision Outcomes Study

2020. "Trident II Revision Outcomes Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04317586.